These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 31289519)
21. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers. Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036 [TBL] [Abstract][Full Text] [Related]
22. The incidence of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in Saudi adult patients with renal cancer: a retrospective tissue microarray analysis. Al-Maghrabi J; Mufti S; Gomaa W Pol J Pathol; 2018; 69(4):376-383. PubMed ID: 30786687 [TBL] [Abstract][Full Text] [Related]
23. Psammoma body and its precursors in papillary thyroid carcinoma: a study by fine-needle aspiration cytology. Das DK; Mallik MK; Haji BE; Ahmed MS; Al-Shama'a M; Al-Ayadhy B; George SS; Sathar SA; Junaid TA Diagn Cytopathol; 2004 Dec; 31(6):380-6. PubMed ID: 15540187 [TBL] [Abstract][Full Text] [Related]
24. Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?: A 10-Year Single-Center Study. Liu N; Gan W; Qu F; Wang Z; Zhuang W; Agizamhan S; Xu L; Yin J; Guo H; Li D Am J Pathol; 2018 Apr; 188(4):929-936. PubMed ID: 29571325 [TBL] [Abstract][Full Text] [Related]
25. Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion. Wang Z; Liu N; Gan W; Li X; Zhang G; Li D; Guo H J Int Med Res; 2017 Aug; 45(4):1287-1296. PubMed ID: 28587544 [TBL] [Abstract][Full Text] [Related]
26. Xp11 Translocation Renal Cell Carcinoma: Unusual Variant Masquerading as Upper Tract Urothelial Cell Carcinoma. Akhavein A; Han J; Carter C; Al-Quran SZ; Su LM Urol Case Rep; 2014 May; 2(3):75-7. PubMed ID: 26955551 [TBL] [Abstract][Full Text] [Related]
27. Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features. Inamura K Cancers (Basel); 2017 Aug; 9(9):. PubMed ID: 28850056 [TBL] [Abstract][Full Text] [Related]
28. The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma. Zhu QQ; Wang ZQ; Zhu WR; Chen WX; Wu JT Acta Radiol; 2013 Apr; 54(3):355-62. PubMed ID: 23446748 [TBL] [Abstract][Full Text] [Related]
29. [Clinical features of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions-single-center study]. Ma WL; Liu N; Zhuang WY; Li XG; Zhang GT; Gan WD; Guo HQ Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(38):3068-3073. PubMed ID: 30392265 [No Abstract] [Full Text] [Related]
30. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma. Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891 [TBL] [Abstract][Full Text] [Related]
33. Unsuspected Xp11 Translocation Renal Neoplasm Associated With Contralateral Clear Cell Carcinoma. D'Antonio A; Addesso M; Nappi O; Zeppa P Int J Surg Pathol; 2016 May; 24(3):248-52. PubMed ID: 26729550 [TBL] [Abstract][Full Text] [Related]
34. Diagnosis of Xp11.2 Translocation Renal Cell Carcinomas in the Thai Patients. Junthaworn B; Pradniwat K; Hanamornroongruang S J Med Assoc Thai; 2015 Nov; 98(11):1133-8. PubMed ID: 26817185 [TBL] [Abstract][Full Text] [Related]
35. [Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: a study of 11 cases and review of literature]. Rao Q; Zhou XJ; Wu B; Ma HH; Zhou HB; Liu XH; Chen JY Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):244-6. PubMed ID: 17706115 [TBL] [Abstract][Full Text] [Related]
36. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Komai Y; Fujiwara M; Fujii Y; Mukai H; Yonese J; Kawakami S; Yamamoto S; Migita T; Ishikawa Y; Kurata M; Nakamura T; Fukui I Clin Cancer Res; 2009 Feb; 15(4):1170-6. PubMed ID: 19228722 [TBL] [Abstract][Full Text] [Related]
37. MiT family translocation renal cell carcinoma after malignant infantile osteopetrosis in childhood: a case report. Wang J; He H; Zhao J; Ma Y; Li K; Chen L Int J Clin Exp Pathol; 2018; 11(7):3770-3776. PubMed ID: 31949762 [TBL] [Abstract][Full Text] [Related]
38. Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH. Xia QY; Wang XT; Ye SB; Wang X; Li R; Shi SS; Fang R; Zhang RS; Ma HH; Lu ZF; Shen Q; Bao W; Zhou XJ; Rao Q Histopathology; 2018 Apr; 72(5):786-794. PubMed ID: 29148086 [TBL] [Abstract][Full Text] [Related]
39. Cyto-histological correlation of Xp11.2 translocation/TFE3 gene fusion associated renal cell carcinoma: Report of a case with review of literature. Manucha V; Sessums MT; Lewin J; Akhtar I Diagn Cytopathol; 2018 Mar; 46(3):267-270. PubMed ID: 29024535 [TBL] [Abstract][Full Text] [Related]
40. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]